An update on autoimmune inner ear disease: A systematic review of pharmacotherapy
Authors:
- 1 January 2020
- journal article
- review article
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 41 (1) , 102310
Abstract
No abstract availableThis publication has 46 references indexed in Scilit:
- IL-1β Is Overexpressed and Aberrantly Regulated in Corticosteroid Nonresponders with Autoimmune Inner Ear DiseaseThe Journal of Immunology, 2011
- A Pilot Study of Rituximab in Immune-Mediated Inner Ear DiseaseAudiology and Neurotology, 2010
- Autoantibodies to recombinant human CTL2 in autoimmune hearing lossThe Laryngoscope, 2009
- Local Perfusion of the Tumor Necrosis Factor α Blocker Infliximab to the Inner Ear Improves Autoimmune Neurosensory Hearing LossAudiology and Neurotology, 2006
- A crucial role for interleukin (IL)-1 in the induction of IL-17–producing T cells that mediate autoimmune encephalomyelitisJournal of Experimental Medicine, 2006
- Immune-mediated inner ear diseaseActa Oto-Laryngologica, 2006
- Etanercept therapy for immune-mediated cochleovestibular disorders: A multi-center, open-label, pilot studyArthritis & Rheumatism, 2005
- A case of possible autoimmune bilateral vestibulopathy treated with steroidsJournal of Neurology, Neurosurgery & Psychiatry, 2003
- Cochlear Function in Ears with Immunomediated Inner Ear DisorderActa Oto-Laryngologica, 2002
- Correlation between antibodies to type II collagen and treatment outcome in bilateral progressive sensorineural hearing lossThe Lancet, 1991